Tripuraneni Radhika
Insider CIK 1761114 · PRTA Chief Development Officer · VRDN Chief Medical Officer · TERN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2026-08-14 | 2026-08-18 | 40,000 | — | $0 | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2026-08-14 | 2026-08-18 | 40,000 | $13.21 | $528.4K | 40,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2026-08-14 | 2026-08-18 | 40,000 | — | $0 | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2026-08-14 | 2026-08-18 | 40,000 | $13.21 | $528.4K | 40,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 1,697 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 4,676 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 32,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 32,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 10,657 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 45,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 64,000 | — | $0 | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2026-03-02 | 2026-03-04 | 19,150 | — | $0 | 19,150 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2026-03-02 | 2026-03-04 | 95,800 | — | $0 | 95,800 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2026-02-01 | 2026-02-02 | 1,697 | — | $0 | 1,697 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2025-06-11 | 2025-06-12 | 45,000 | — | $0 | 45,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2025-03-10 | 2025-03-12 | 310,700 | — | $0 | 310,700 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2025-02-01 | 2025-02-03 | 10,657 | — | $0 | 10,657 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2024-07-01 | 2024-07-02 | 4,676 | — | $0 | 4,676 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2024-06-10 | 2024-06-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2022-07-26 | 2022-07-28 | 64,000 | — | $0 | 64,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2022-02-23 | 2022-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-25 | 2021-02-26 | 56,000 | — | $0 | 56,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 50,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 37,037 | — | $0 | 37,037 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2020-02-25 | 2020-02-27 | 70,000 | — | $0 | 70,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2019-02-27 | 2019-03-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2018-12-11 | 2018-12-13 | 35,000 | — | $0 | 35,000 | SEC↗ |